Houston—Identification of the cellular and genetic abnormalities involved in all types of cancer is providing new therapeutic avenues for researchers to pursue. Efforts to translate this knowledge into innovative therapies for ovarian cancer took the spotlight at the first International Conference on Ovarian Cancer, held at the University of Texas last month.
Ovarian cancer, which has the highest mortality rate of all gynecologic cancers and is the fourth leading cause of cancer deaths among women in the United States, can usually be treated and cured if caught early. But all too often, it causes only vague symptoms that go unnoticed until the tumor is advanced and the prognosis is poor.
Friedrich MJ. Ovarian Cancer Investigators Aim at Cell Signaling Pathways. JAMA. 1999;281(11):973–975. doi:10.1001/jama.281.11.973
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.